Open | 0.87 |
Previous Close | 0.86 |
Day Range | 0.85 - 1.09 |
52-Week Range | 0.40 - 1.73 |
All-Time High | 116.90 |
Avg. Volume (50-day) | 603,361.25 |
EPS (TTM) | -0.90 |
Next Earnings Date | - |
Last Earnings Date | - |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | -0.96 |
PEG Ratio | - |
Price to Book | 1.31 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 0.51 M |
Revenue per Share (TTM) | 0.04 |
Shares Outstanding | 12.976 M |
Share Float (%) | 11.24 M |
% Held by Institutions | 3.15 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.73 (+45.21%) |
+/- SMA(50) | 0.61 (+73.77%) |
+/- SMA(200) | 0.64 (+65.63%) |
5-Day Perf. | +49.34% |
1-Month Perf. | +53.6% |
3-Month Perf. | +79.66% |
6-Month Perf. | +55.11% |
YTD Perf. | +79.66% |
1-Year Perf. | -19.08% |
RSI(14) | 82.97 |
ATR(14) | 0.07 |
ADX(14) | 49.27 |
Beta (5Y) | 0.20 |
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
ABVC has triggered the following predefined scans:
Improving Chaikin Money Flow |
Strong Volume Gainers |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.